Home
Bristol Myers Squibb BMY spent $2.2M on lobbying in Q2 2023 · Health Issues, Medicare and 3 more issues
Trade details
- Type
- Lobbying report
- Amount
- $2,230,000
- Quarter
- Q2 2023
- Reported
- 23/07/19
Down 7.5% from last quarter
What else happened in Bristol Myers Squibb around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Bristol-Myers Squibb Company's other lobbying reports
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$50K
$50K
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$80K
$80K
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$3.2M
$3.2M
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
Under $5,000
Under $5,000
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$60K
$60K
Reported 07/20
for Q2